Will Shrank: The Trillion-Dollar Question Facing CGT Access | Pharmaceutical Commerce
Will Shrank, MD, breaks down why payers, providers, and manufacturers are all struggling to keep pace with a rapidly expanding cell and gene therapy pipeline — and what it will take to fix it.
pharmaceuticalcommerce.com